These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2122925)

  • 1. Differential expression of CD8 alpha and CD8 beta associated with MHC-restricted and non-MHC-restricted cytolytic effector cells.
    Baume DM; Caligiuri MA; Manley TJ; Daley JF; Ritz J
    Cell Immunol; 1990 Dec; 131(2):352-65. PubMed ID: 2122925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function.
    Moretta A; Tambussi G; Bottino C; Tripodi G; Merli A; Ciccone E; Pantaleo G; Moretta L
    J Exp Med; 1990 Mar; 171(3):695-714. PubMed ID: 2137855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of CD3- and CD3+ CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression.
    Ortaldo JR; Winkler-Pickett RT; Yagita H; Young HA
    Cell Immunol; 1991 Sep; 136(2):486-95. PubMed ID: 1714795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct granzyme expression in human CD3- CD56+ large granular- and CD3- CD56+ small high density-lymphocytes displaying non-MHC-restricted cytolytic activity.
    Smyth MJ; Browne KA; Kinnear BF; Trapani JA; Warren HS
    J Leukoc Biol; 1995 Jan; 57(1):88-93. PubMed ID: 7530284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody.
    Aramburu J; Balboa MA; Ramírez A; Silva A; Acevedo A; Sánchez-Madrid F; De Landázuri MO; López-Botet M
    J Immunol; 1990 Apr; 144(8):3238-47. PubMed ID: 1691231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.
    Finke JH; Rayman P; Alexander J; Edinger M; Tubbs RR; Connelly R; Pontes E; Bukowski R
    Cancer Res; 1990 Apr; 50(8):2363-70. PubMed ID: 2107973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental regulation of a mucinlike glycoprotein selectively expressed on natural killer cells.
    Vivier E; Sorrell JM; Ackerly M; Robertson MJ; Rasmussen RA; Levine H; Anderson P
    J Exp Med; 1993 Dec; 178(6):2023-33. PubMed ID: 7504054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2-activated murine cell lines with macrophage- and B-lymphoblast-lytic activity.
    Suzuki H; Ikemoto M; Yokoyama A; Kamitani T; Yamashita N; Maruyama M; Yano S
    Cell Immunol; 1991 Jan; 132(1):127-39. PubMed ID: 1829651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.
    Ferrini S; Cambiaggi A; Meazza R; Sforzini S; Marciano S; Mingari MC; Moretta L
    Eur J Immunol; 1994 Oct; 24(10):2294-8. PubMed ID: 7925558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-MHC-restricted target-cell lysis by a CD4-CD8- TCR alpha beta T-cell line, as well as by TCR gamma delta T-cell lines, results from lymphokine-activated killing.
    Maziarz RT; Groh V; Prendergast M; Fabbi M; Strominger JL; Burakoff SJ
    Int J Cancer; 1991 Apr; 48(1):142-7. PubMed ID: 1902200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.
    Moretta A; Poggi A; Pende D; Tripodi G; Orengo AM; Pella N; Augugliaro R; Bottino C; Ciccone E; Moretta L
    J Exp Med; 1991 Dec; 174(6):1393-8. PubMed ID: 1720808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells.
    Falk CS; Steinle A; Schendel DJ
    J Exp Med; 1995 Oct; 182(4):1005-18. PubMed ID: 7561674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of MHC-unrestricted cytotoxic activity of human CD56+ CD3- natural killer (NK) cells and CD3+ T cells by rhamnogalacturonan: target cell specificity and activity against NK-insensitive targets.
    Zhu HG; Zollner TM; Klein-Franke A; Anderer FA
    J Cancer Res Clin Oncol; 1994; 120(7):383-8. PubMed ID: 7514604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing their activation.
    Zarcone D; Viale O; Cerruti G; Tenca C; Malorni W; Arancia G; Iosi F; Galandrini R; Velardi A; Moretta A
    Cell Immunol; 1992 Sep; 143(2):389-404. PubMed ID: 1380897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.
    Lanier LL; Le AM; Civin CI; Loken MR; Phillips JH
    J Immunol; 1986 Jun; 136(12):4480-6. PubMed ID: 3086432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of T cell receptors in non-MHC-restricted cytotoxicity.
    Lauzon RJ; Siminovitch KA; Roder JC
    Cell Immunol; 1989 Feb; 118(2):265-84. PubMed ID: 2521308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity.
    Maïza H; Leca G; Mansur IG; Schiavon V; Boumsell L; Bensussan A
    J Exp Med; 1993 Sep; 178(3):1121-6. PubMed ID: 7688788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of large and small CD3- CD56+ lymphocytes mediating NK-associated activities.
    Ortaldo JR; Winkler-Pickett R; Kopp W; Kawasaki A; Nagashima K; Okumura K; Yagita H; Bach FH
    J Leukoc Biol; 1992 Sep; 52(3):287-95. PubMed ID: 1381742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
    van de Griend RJ; Tax WJ; van Krimpen BA; Vreugdenhil RJ; Ronteltap CP; Bolhuis RL
    J Immunol; 1987 Mar; 138(5):1627-33. PubMed ID: 2949018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.
    Moretta A; Bottino C; Pende D; Tripodi G; Tambussi G; Viale O; Orengo A; Barbaresi M; Merli A; Ciccone E
    J Exp Med; 1990 Dec; 172(6):1589-98. PubMed ID: 2147946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.